Achieving and maintaining pregnancy after age 40

International Journal of Fertility and Women's Medicine

Volumn 43, Issue 5, 1998, Pages 249-256

  Corso, Stephen L ^a,b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b GRADUATE HOSPITAL   (United States)

Author keywords

Aging; Assisted reproduction; Clomiphene citrate challenge test (C3T); Ovarian reserve

Indexed keywords

CLOMIFENE CITRATE; ESTRADIOL; ESTROGEN; FOLLITROPIN; PROGESTERONE; SEX HORMONE;

ADULT; AGING; COST CONTROL; DIAGNOSTIC VALUE; FEMALE; FEMALE FERTILITY; FERTILIZATION IN VITRO; HUMAN; LUTEINIZING HORMONE RELEASE; MENSTRUAL CYCLE; OOCYTE DONATION; OVARY FOLLICLE; OVARY FUNCTION; OVULATION INDUCTION; PREGNANCY; PRIORITY JOURNAL; PROVOCATION TEST; REVIEW; SEX HORMONE DETERMINATION; SPONTANEOUS ABORTION; TREATMENT OUTCOME; UNITED STATES;

ADULT; AGE DISTRIBUTION; AGE FACTORS; CLOMIPHENE; ESTRADIOL; FEMALE; FERTILITY AGENTS, FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; MATERNAL AGE; MIDDLE AGED; OVARIAN FUNCTION TESTS; PREGNANCY; PREGNANCY MAINTENANCE; PREGNANCY, HIGH-RISK; REPRODUCTION;

EID: 0031793015     PISSN: 1534892X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. Acheson LS: Perinatal, infant, and child death rates among the Old Order Amish. Am J Epidemiol 139:173-183, 1994.
2. Corsan G, Trias A, Trout S, et al: Ovulation induction combined with intrauterine insemination in women 40 years of age and older: is it worthwhile? Hum Reprod 11:1109-1112, 1996.
3. Pearlstone AC, Fournet N, Gambone JC, et al: Ovulation induction in women age 40 and older: the importance of basal follicle-stimulating hormone level and chronological age. Fertil Steril 58:674-679, 1992.
4. Smith KE, Buyalos RP: The profound impact of patient age on pregnancy outcome after early detection of fetal cardiac activity. Fertil Steril 65:35-40, 1996.
5. Klein NA, Battaglia DE, Fugimoto VY, et al: Reproductive aging: Accelerated ovarian follicular development associated with a monotropic folliclestimulating hormone rise in normal older women. J Clin Endocrinol Metab 81:1038-1045, 1996.
6. Navot D, Rosenwaks Z, Margalioth EJ: Prognostic assessment of female fecundity. Lancet 2:645-647, 1987.
7. Faddy MJ, Gosden RG, Cougeon A, et al: Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod 7:1342-1346, 1992.
8. Scott RT, Leonardi MR, Hofmann GE, et al: A prospective evaluation of clomiphene citrate challenge test screening in the general infertility population. Obstet Gynecol 82:539-545, 1993.
9. Scott RT, Oposahl MS, Leonardi MR, et al: Life table analysis of pregnancy rates in a general infertility population relative to ovarian reserve and patient age. Hum Reprod 10:1706-1710, 1995.
10. Hershlag A, Lesser M, Montefusco D, et al: Interinstitutional variability of follicle-stimulating hormone and estradiol levels. Fertil Steril 58:1123-1126, 1992.
11. Hansen LM, Batzer FR, Gutmann JN, et al: Evaluating ovarian reserve: follicle stimulating hormone and oestradiol variability during cycle days 2-5. Hum Reprod 11:486-489, 1996.
12. Scott RT, Jr, Hofmann GE: Prognostic assessment of ovarian reserve. Fertil Steril 63:1-11, 1995.
13. Licciardi FL, Liu H-C, Rosenwaks Z: Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization. Fertil Steril 64:991-994, 1995.
14. Smotrich DB, Widra RA, Gindoff PR, et al: Prognostic value of day 3 estradiol on in vitro fertilization outcome. Fertil Steril 64:1136-1140, 1995.
15. Hofmann GE, Sosnowski J, Scott RT, Jr, et al: Efficacy of selection criteria for ovarian reserve screening using the clomiphene citrate challenge test in a tertiary fertility center population. Fertil Steril 66:49-53, 1996.